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Abstract:  Time-of-flight mass spectrometry along with statistical analysis was utilized to study 
metabolic profiles among rats fed resistant starch (RS) diets.  Fischer 344 rats were fed four 
starch diets consisting of 55% (w/w, dsb) starch.  A control starch diet consisting of corn starch 
was compared against three RS diets.  The RS diets were high-amylose corn starch (HA7), HA7 
chemically modified with octenyl succinic anhydride, and stearic-acid-complexed HA7 starch. 
A subgroup received antibiotic treatment to determine if perturbations in the gut microbiome 
were long lasting.  A second subgroup was treated with azoxymethane (AOM), a carcinogen.  At 
the end of the 8-week study, cecal and distal colon contents samples were collected from the 
sacrificed rats.  Metabolites were extracted from cecal and distal colon samples into acetonitrile. 
The extracts were then analyzed on an accurate-mass time-of-flight mass spectrometer to obtain 
their metabolic profile.  The data were analyzed using partial least-squares discriminant analysis 
(PLS-DA).  The PLS-DA analysis utilized a training set and verification set to classify samples 
within diet and treatment groups.  PLS-DA could reliably differentiate the diet treatments for 
both cecal and distal colon samples.  The PLS-DA analyses of the antibiotic and no antibiotic-
treated subgroups were well classified for cecal samples and modestly separated for distal colon 
samples.  PLS-DA analysis had limited success separating distal colon samples for rats given 
AOM from those not treated; the cecal samples from AOM had very poor classification. Mass 
spectrometry profiling coupled with PLS-DA can readily classify metabolite differences among 
rats given RS diets. 
Keywords: Resistant Starch, Mass Spectrometry, Metabolites, PLS-DA 
Introduction 
Food is composed of three main components, which are protein, lipid and starch.  Cereal 
grains are one of the world’s most important food sources; of these, its most abundant 
component is typically starch.  Amylopectin and amylose make up the bulk of starch granules; 
their relative concentration can vary depending on source material.  Amylopectin comprises 
The article is from  Analytical and Bioanalytical Chemistry 406 (2014): 745. Posted with permission. The final 
publication is available at Springer via http://dx.doi.org/10.1007/s00216-013-7523-8.
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typically about 70 % of the starch granule but can reach 100 % for waxy corn varieties.  
Amylose levels are typically about 15–30 % of the starch granule [1-3].   
Both amylopectin and amylose are comprised of polymeric glucose.  Recent studies have 
shown that amylose forms double helical structures, and the hydroxyl groups of the individual 
glucose units may be esterified with a variety of lipid-like compounds [3].   Amylose can also 
form single helical complexes with free fatty acids and iodine.  These modified amylose structures 
along with food materials that contain up to 85 % amylose are examples of resistant starch (RS) 
[3], which effectively resist digestion in the stomach and small intestine, and thus are processed 
farther along the gut [4].  
RS has been studied for a variety of health benefits.  RS may aid diabetics, decrease 
energy density, and also act as a prebiotic [5-10].  Prebiotics are materials which resist digestion 
by the host and are metabolized in the gut by microorganisms [10].  The microorganisms release 
compounds, such as short-chain fatty acids, which are believed to be beneficial to the host 
organism [11, 12].  The interplay between microorganisms and host is complex; the 
microorganisms may even interact with host diet to increase deleterious conditions such as 
intestinal inflammation [13].  Some materials, such as oligofructose, lactulose, and transgalacto-
oligosaccharides are well characterized and known to be prebiotics, but only recently has RS 
been classified as a prebiotic [14-20].    
The catabolism of prebiotics by microorganisms produces a vast array of chemical 
components, which are classified as metabolites [21].  Metabolites from gut microorganisms can 
be obtained from blood, urine, or feces [22-24].  Blood and urine reflect metabolic changes that 
occur in the gut from direct absorption through the intestinal lining [25, 26].  Feces are complex 
media from which a direct interplay between microorganism and host can be observed [27]. 
 There are five RS categories.  Whole grains and ground legumes contain type 1 RS.  
Type 1 RS is amylose protected by cell wall material and other plant materials that are difficult 
to digest.  Type 2 RS retains a crystalline structure, which resists enzyme hydrolysis, and is 
found primarily in banana and potato starch.  Type 3 RS is retrograded starch; this occurs when 
the starch granule has gelatinized and reformed a crystalline structure [28].  Type 4 RS is a 
chemically modified starch molecule.  To produce the type 4 RS, a lipid compound such as 
octenyl succinic anhydride is generally bound to the various hydroxyl groups of glucose within 
the starch amylose molecule [14, 29].  Type 5 RS is formed from a physical interaction of 
debranched helical starch amylose and a long chain fatty acid, such as palmitic or stearic acid 
[30].  
 Mass spectrometry has emerged as one of the most important platforms for metabolite 
analysis due to improvements in ionization methodology and high-resolution instruments.  A 
variety of metabolite separation methods can be coupled with mass spectrometers.  The coupling 
allows comprehensive analysis through fingerprinting or profiling of metabolites [31, 32].  Gas 
chromatography-mass spectrometry (GC-MS) is useful for the analysis of thermally stable 
volatile compounds.  GC-MS often utilizes electron impact (EI) ionization.  The GC separation 
and subsequent EI fragmentation often allow metabolite identification through database 
searching [27, 33-35].  Liquid chromatography-mass spectrometry (LC-MS) is very useful for 
metabolite analysis because specialized columns can be used to separate either polar or non-polar 
compounds [25, 26, 36].  LC-MS can also be coupled with collision induced dissociation that 
provides fragment ions for potential metabolite identification [28, 37].  Capillary electrophoresis 
(CE) is another separation technique that can be used prior to mass spectrometry analysis [38, 
39].  Work performed with CE and LC-MS has attempted to identify metabolites using standard 
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retention time libraries and elemental formulas from accurate mass measurements [40].  Ultra-
high resolution mass spectrometry using Fourier transform ion cyclotron resonance instruments 
has been used for metabolite analysis [41, 42].  Even matrix-assisted laser desorption ionization 
imaging has recently been coupled with mass spectrometry to obtain metabolite insight [43].   
 Statistical tools have become important in the postexamination of metabolites analyzed 
using mass spectrometry.  Tools such as principal component analysis, soft independent 
modeling of class analogy, partial least-squares discriminant analysis (PLS-DA), linear 
discriminant analysis, and artificial neural networks all allow differentiation and group prediction 
[26, 27, 34, 35, 39, 44-46].  Using these tools, difficult and complex analyses of large amounts of 
data can be more easily graphed and visualized. 
 The current study describes such methods for profiling the metabolites from rat cecal and 
distal colon contents to deduce differences among RS diets.  Three different RS and a control 
corn starch were fed to rats.  The first RS was a type 2 RS that consisted of high amylose corn 
starch (HA7).  The second RS was a type 4 RS that was HA7 corn starch modified with octenyl 
succinic anhydride (OS-HA7).  The last RS was a type 5 RS that was produced by complexing 
HA7 with stearic acid (StA-HA7).  The main goal of this study was to determine whether 
statistical tools, such as PLS-DA, could observe differences among RS starch diets from rat cecal 
and distal colon contents using mass spectrometry.  Another goal was to understand whether 
statistical tools could accurately group diets and target their individual biomarkers that vary the 
most among the diets.  
 
 
Materials and methods 
 
Animal study 
 
 Male Fischer 344 rats were housed and fed according to the procedure of Zhao et al. [47]. 
The study initially used 90 rats (two died before sacrifice) that were obtained at 5 weeks old and 
were placed on specific feeding regimens for 8 weeks, as shown in the flow diagram in Fig. 1.  
The animals were randomly separated into four starch diet groups:  Control, HA7, OS-HA7, and 
StA-HA7.  The control and StA-HA7 starch diet groups each had 29 rats, and both diets 
contained four further subgroup treatments.  Rats fed HA7 and OS-HA7 starch diets had 15 rats 
each, and both diets contained only two further subgroup treatments.  All four starch diet groups 
were divided into two treatment subgroups, which consisted of 9–10 rats given either two 
injections of the carcinogen azoxymethane (AOM, Midwest Research Institute, Kansas City, 
MO, USA) at a dose of 20 mg AOM/kg rat body weight and 4–5 rats given two injections of 
saline administered 8 weeks prior to sample collection, following the method of Zhao et al. [47].  
In the control and StA-HA7 diet groups, both of the injection subgroups were further split into 
two more subgroups consisting of rats either administered an antibiotic consisting of a 
combination of imipenem and vancomycin at a dose of 50 µg/mL each in the drinking water in 
week 2 (Fig. 1) or not administered any antibiotic. 
 
Starch diet materials 
 
Normal corn starch (NCS, Cargill GelTM) and HA7 (AmyloGelTM) were purchased from 
Cargill Inc. (Minneapolis, MN, USA), 2-octen-1-ylsuccinic anhydride (OSA), pullulanase 
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from Bacillus acidopullulyticus and stearic acid (SA) were purchased from Sigma-Aldrich Co. 
(St. Louis, MO, USA).  All starch was cooked prior to addition to the rat diets, in accordance 
with the procedure of Zhao et al. [47].  The nonstarch component of the rat diet was prepared in 
compliance with the standards of the American Society for Nutritional Sciences for mature rats 
(AIN-93M) [48].  The diets were prepared every other day and served fresh to the rats. 
 
Preparation of OS-HA7 starch diet 
 
 OS-HA7 was produced from the HA7 through modification with OSA [49].  The HA7 
was suspended in water at a concentration of 35 % (w/w, dsb).  The pH of the starch slurry was 
adjusted to 8.0 by adding a sodium hydroxide aqueous solution (3 %, w/w), and the temperature 
was maintained at 35 °C.  OSA (10 %, w/w, dsb) was added to the slurry dropwise while 
maintaining the pH at 8.0 and 35 °C.  After the reaction was completed, the pH of the starch 
slurry became stable and was then adjusted to 6.5 by adding 1.0 M hydrochloric acid.  The starch 
was recovered using filtration, washed with distilled water and 100 % ethanol, dried at 37 °C, 
and then ground to fine powder. 
 
Preparation of StA-HA7 starch diet 
 
 StA-HA7 was prepared from the HA7 following the method of Hasjim et al. [30] with 
modifications.  The HA7 was suspended in water at a concentration of 10 % (w/w, dsb).  The 
Fig. 1  Flow diagram of the animal study detailing the treatment schedule for AOM, antibiotic, and
diet up until sacrifice. The diets that were given for weeks 4-10 are represented as the abbreviations
cont (Control), HA7 (HA7), OS (OS-HA7), and StA (StA-HA7).  The amount of rats in each group of
the flow chart are represented by the letter “n”  
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starch slurry was pre-heated to 80 °C, and the temperature maintained for 1 h with stirring.  
Pullulanase (5 U/g starch, dsb) was added to the slurry to hydrolyze α 1-6 branch linkages of the 
starch at 60 °C for 24 h.  Stearic acid (SA, 10 %, w/w, dsb) was added, and the mixture was kept 
at 80 °C for 1 h with vigorous stirring for amylose-SA complex formation.  After cooling to 
room temperature, the StA-HA7 was recovered using centrifugation, washed with 50 % (v/v) 
aqueous ethanol solution, dried at 37 °C, and then ground. 
 
Rat cecal samples 
 
 The rat cecum was removed just after sacrifice.  The cecum contents were placed in 15-
mL centrifuge tubes (Corning, Tewksbury, MA, USA) and stored on dry ice until placed in long 
term storage at -80 °C.  Of the 88 rats sampled, 81 cecal samples were analyzed.  For control, 
HA7, OS-HA7, and StA-HA7 diets, 24, 15, 14, and 28 samples were analyzed, respectively.  The 
lower number of samples analyzed for the control diet was due to reduced sample volume.  All 
RS fed rats had ceca of substantial size; on average they were nearly four times the mass of the 
control.  
 
Rat distal colon samples 
 
 After sacrifice, the rat colon was opened.  Fecal pellets were collected from the large 
intestine starting from the anus to 5 cm up the colon and were placed in 15-mL centrifuge tubes 
containing phosphate buffer.  The samples were placed on dry ice, and then stored long term at   
-80 °C.  Seventy-two distal colon samples were analyzed from the original 88 rats. From control, 
HA7, OS-HA7, and StA-HA7 diets, 22, 13, 11, and 26 samples were analyzed, respectively.  The 
drop in samples analyzed in respect to cecum samples was due to random amounts of fecal 
pellets in the colon.  Some rats contained many pellets, while some had none at the time of 
sacrifice. 
 
Metabolite extraction for cecal and distal colon samples 
 
 The metabolite extraction was an adaption of the method of Antunes et al. [42].  Frozen 
cecal and distal colon samples were thawed and approximately 150 mg of sample was placed in a 
2.0-mL microcentrifuge tube (Eppendorf, Hamburg, Germany).  The tube was then half-filled 
with 1 mm zirconia/silica beads (Biospec Products, Bartlesville, OK, USA) and 1 mL of HPLC 
grade acetonitrile (Fischer Scientific, Fair Lawn, NJ) was introduced.  The microcentrifuge tubes 
were placed on a vortex apparatus (Fisherbrand, Bohemia, NY, USA) with an orbital bead 
homogenizing adaptor (Mo Bio Laboratories Inc., Carlsbad, CA, USA).  The samples were 
vortexed until homogenized.  The liquid portion of each sample was then pipetted into a clean 
microcentrifuge tube.  The samples were placed in a centrifuge (Model 5415C, Eppendorf, 
Westbury, NY, USA) for 5 min at 12,000 rpm.  From the centrifuge tube, 500 µL of supernatant 
was placed in a clean centrifuge tube, then vacuum centrifuged (Labconco Corporation, Kansas 
City, MO, USA) at 50 °C and depressurized with a dry vacuum pump (Welch Rietchle Thomas, 
Skokie, IL, USA).  The dried metabolite extracts were stored at -20 °C. 
 The dried metabolite extracts were reconstituted for mass spectrometry analysis by 
adding 500  µL of a 60 % (v/v) aqueous acetonitrile solution.  The extract was vigorously 
vortexed and then centrifuged for 2 min at 12,000 rpm.  One hundred microliters of supernatant 
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was removed and placed in a clean microcentrifuge tube.  An additional 500 µL of 60 % (v/v) 
aqueous acetonitrile was added to dilute the sample.  Formic acid was added to produce a 0.2 % 
formic acid sample solution to aid in positive ion production by electrospray ionization (ESI).  
Lastly, the solution was vortexed and transferred into 12- × 35-mm clear glass vials to be placed 
in an LC autosampler. 
 
Mass Spectrometry 
 
 From the reconstituted cecal and distal colon metabolite extracts, 20 µL of sample was 
injected into an Agilent 1260 Infinity LC system (Agilent Technologies, Inc., Santa Clara, CA, 
USA), which was used as an autosampler.  The samples were direct-infused from the LC and 
ionized using ESI in positive mode on an Agilent 6224 time-of-flight mass spectrometer 
operated at an acquisition rate of 4 GHz.  A sample run lasted 5 min with a mobile phase of 60 % 
(v/v) aqueous acetonitrile.  A second mobile phase of 60 % (v/v) aqueous acetonitrile with 20 
ppm of a 50:50 mixture of polyethylene glycol (PEG) 200 and 600 standards (Hampton 
Research, Aliso Viejo, CA, USA) was used for calibration.  At 48 s into a sample run, the PEG-
containing mobile phase was used for 12 s.  At 1 min, the primary mobile phase was switched 
inline and flushed the PEG calibrant from the system prior to the next sample.   
 The software used was Agilent MassHunter Qualitative Analysis.  Each spectrum was 
background subtracted, and the m/z scale was recalibrated using 17 ammoniated PEG-adduct 
peaks ranging from m/z 168.1236 to 872.5430.  The calibrated spectra were centroided and 
exported as text files.  The text files for each diet and subgroup were averaged using custom 
software.  The averaged text files were then uploaded to the MassTRIX website, and accurate 
mass data were compared to rat metabolites in the KEGG database [50].  
 
 
 
Statistical analysis 
 
 Separate PLS-DA classification models were developed using commercial software 
(Pirouette Version 4.5; Infometrix, Inc.; Bothell, WA, USA) for diet, AOM treatment, and 
antibiotic treatment.  The cecal and distal fecal datasets were modeled separately.  The cecal and 
distal fecal datasets consisted of spectra from 81 and 72 rats, respectively.  These sets included 
data from AOM-treated and antibiotic-treated rats, as well as untreated ones.  The verification set 
consisted of 25 % of the total number of samples, and the remaining 75 % of samples were 
placed in the training set.  The verification set was comprised of as close to one quarter of diet, 
AOM, and antibiotic treated samples as possible to ensure equal weighting during classification.  
The appropriate number of rats from each treatment was randomly selected for the verification 
set without previous knowledge of the spectral results.  Each spectrum was normalized so that 
the base peak had an intensity of 100.  Small peaks with intensities below one were then 
eliminated.  The data were aligned using a mass tolerance of 0.005 m/z so that peaks in different 
spectra within a range of m/z ~ 0.010 were assigned the same (average) mass.  In PLS-DA, each 
training-set spectrum is assigned a class-fit value of one for any class to which its sample 
belongs and a class-fit value of zero for classes to which its sample does not belong.  When the 
verification set is analyzed, the resulting model determines the class-fit values of each spectrum 
for every class.  Each verification-set spectrum is then assigned to the class for which its class-fit 
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value is closest to one, which usually means the 
one class for which its class-fit value is above 
0.5. 
 Prior to modeling, the spectra were 
always mean-centered and for some models 
one-component orthogonal signal correction 
was used [51].  The resulting regression vectors 
for the classes (e.g., diets) were used to identify 
those peaks that most strongly differentiate the 
classes, and the corresponding species were 
examined as possible biomarkers. 
 
Results and discussion 
 
Mass spectrometry 
 
 Even without the mass spectrometry 
analysis, there were obvious differences in the 
digestive-tract contents of rats fed different 
diets.  As described previously, the RS fed rats 
had ceca, which were as much as four times 
greater in mass than the rats on the control diet.  
The increased mass may have been due to 
increased fermentation time in the cecum to 
obtain nutrients from resilient RS components.  
The color, consistency, and aroma of the cecal 
contents were much different for the control 
compared to the RS diets.  These differences 
may be linked to the amount of the starch 
fermented and thus tied to the gut 
microorganisms and metabolites.  The primary 
difference among distal colon contents was that the various diets had distinct colors.   
Mass spectra of metabolites from the cecal contents of rats that were fed with different 
diets and received no AOM or antibiotic were averaged and are compared in Fig. 2.  The main 
emphasis of the study was to determine differences among diets in respect to their metabolite 
profiles.  A metabolite peak was considered specific to a diet group if the peak was 
approximately three times the intensity of the same peak in the other diets.  The peaks are given 
letter labels in the figure, and Table 1 lists their m/z values and the diets in which they were 
found.  First, the peaks that were specific to only one diet group were inspected.  The control 
group had four specific peaks labeled y, z, aa, and ai.  The HA7 group had no specific peaks.  
The OS-HA7 group contained six specific peaks marked c, p, w, ad, ag, and aj.  The last group, 
StA-HA7, had four specific peaks labeled t, u, ah, and ak.  Far fewer metabolite peaks were 
shared between any two of the groups.  The ab peak was shared by the control and HA7 groups. 
Another peak, labeled f, was in both the control and StA-HA7 groups.  The HA7 and StA-HA7 
groups had five mutual peaks marked e, i, j, n and r.  Fewer peaks were observed among three 
common groups.  The control, HA7, and StA-HA7 diets shared the g peak.  The control, OS-
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Fig. 2  Averaged mass spectra of cecal content 
samples from each diet group with no AOM or 
antibiotic treatments.  The peak intensities have 
been normalized against the strongest peak in 
the spectrum for each diet.  The most prominent 
metabolite peaks in each diet have been labeled 
and can be matched to their respective m/z in 
Table 1 
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HA7, and StA-HA7 diets contained a single 
peak in common, labeled h. The HA7, OS-HA7 
and StA-HA7 diet groups shared the three 
peaks b, k and s.  Only one prominent 
metabolite was observed in all groups; it was 
the d peak.   
 Mass spectra of the diet treatment 
metabolites in the distal colon contents are 
compared in Fig. 3.  Similarly to the cecal 
contents, the mass spectra for the distal colon 
contents were averaged from rats that received 
no AOM or antibiotic.  The peaks were also 
classified as specific to diet groups if they were 
approximately three times the intensity of the 
other diet groups.  Like the labeled cecal-
contents peaks in Fig. 2, further information 
about the lettered peaks in Fig. 3 can be found 
in Table 1.  No peaks were observed to be 
specific to the control group.  The HA7 group 
had only one exclusive peak, labeled af.  The 
OS-HA7 group had seven peaks—m, p, q, w, 
ad, ae, and aj.  Lastly, StA-HA7 had the six 
peaks k, l, o, t, ac, and ak.  Fewer metabolite 
peaks were shared between any two groups 
than the peaks specific to a single group.  The 
control and StA-HA7 diet groups shared the 
four peaks a, g, x and ah.  The HA7 and StA-
HA7 diets contained five common peaks—j, n, 
r, s, and v.  Only the metabolite h was shared 
among the control, OS-HA7, and StA-HA7 diet 
groups.  The two peaks b and d were shared 
among all four diet groups.   
 Analysis of the mass spectra in Figs. 1 and 2 highlighted modest differences between the 
cecal and distal colon contents.  Spectra for the control and StA-HA7 diet group for both 
digestive locations have been placed in Fig. 4 for comparison.  Specific peaks across digestive 
locations for a diet group were chosen with the same rule as described above for Figs. 2 and 3, 
and the peaks are again identified in Table 1.  The control group for the cecal contents contained 
peaks labeled y, z, aa, ab, and ai, which were more intense than the same peaks in the distal 
colon contents.  The distal colon contents contained the four peaks labeled g, l, x, and ac, which 
were more intense than those same peaks observed in the cecal contents.  Both digestive 
locations shared the peaks a, b, d, f, h, and ah with similar intensities.  The StA-HA7 group for 
both cecal and distal colon digestive locations was more complex than the control group.  The 
cecal contents contained only one peak, labeled ah, that was more intense than in the distal colon 
contents.  Peaks g, l, o, and ac had higher intensities in the distal colon contents than in the cecal 
contents. Peaks labeled a, b, d, f, h, j, k, n, r, s, t, u and ak were at similar intensities in the cecal 
and distal colon contents.  
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Fig. 3  Averaged mass spectra of distal colon 
content samples from each diet group with no 
AOM or antibiotic treatments.  The peak 
intensities have been normalized against the 
strongest peak in the spectrum for each diet.  
The most prominent metabolite peaks in each 
diet have been labeled and can be matched to 
their respective m/z in Table 1 
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From this scrutiny of the mass spectra 
of the cecal contents and distal colon contents 
for the diets, it is apparent that RS diets altered 
the metabolism of the rats.  In Table 1 the cecal 
contents from each diet had a distinct 
metabolite profile. Of the 27 labeled 
metabolites, 52 % were specific to only one diet 
group.  These differences among diets persisted 
into the distal colon contents, for which 54 % 
of the 26 labeled metabolites in Table 1 were 
exclusive to individual diet groups.  Figure 4 
compared the cecal and the distal colon 
contents of the control diet, Table 1 described 
that 77 % of the 13 labeled metabolites are 
specific to one or the other digestive location. 
Figure 4 also compared spectra of cecal and 
distal colon contents of the StA-HA7 diet, and 
22 metabolites from Table 1 were specific to 
only 45 % of either digestive location.  For the 
control, there appears to be substantial change 
to the metabolite profile.  However, for RS, 
such as StA-HA7, there was less variability in 
the metabolite profile from cecum to distal 
colon. 
In a companion study to this one that 
used the same samples, Anderson et al. [52] 
determined through enzymatic assay that the 
average cecal starch content (dsb) for the 
control, HA7, OS-HA7, and StA-HA7 diets 
were 0.7, 18.3, 48.8, and 21.9 %, respectively.  
The residual starch differences are most likely 
attributed to the ability of each starch to be 
fermented in the cecum.  The control and OS-HA7, which were the most and least fermented 
diets, respectively, had more diet-specific metabolites for both cecal and distal contents.  The 
HA7 and StA-HA7 RS diets had nearly the same degree of fermentation and also shared many 
metabolites in the cecal and distal colon contents.  The HA7 and StA-HA7 similarities also could 
be due to the relationship between the diets; StA-HA7 was produced from a complex of HA7 and 
stearic acid, and StA-HA7 may share some of the fermentation products of its parent RS.  
Regardless, the degree of fermentation and the nature of the starch source are probably the 
largest factors regarding the divergence of the metabolite profiles.  
 
Statistical analysis of cecal contents 
 
 Classification analysis of the mass spectra for the RS diet groups was performed with 
PLS-DA for the cecal extracts.  PLS-DA modeling was done for the cecal contents with a 61 
sample training set, and a 20 sample verification set.  The verification set contained six, four, 
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Fig. 4  Averaged mass spectra comparison of 
cecal and distal colon content samples from two 
example diets with no AOM or antibiotic 
treatments.  The peak intensities have been 
normalized against the strongest peak in the 
spectrum for each diet.  The most prominent 
metabolite peaks in the spectra have been 
labeled and can be matched to their respective 
m/z in Table 1 
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three, and seven samples from the control, 
HA7, OS-HA7, and StA-HA7 diets, 
respectively.  The PLS-DA analysis of cecal contents for diet correctly classified all training-set 
samples; all verification-set samples were classified properly.  Figure 5 displays the PLS-DA 
results and the quality of separation for the cecal contents RS diet groups.  The closed and open 
symbols correspond to verification-set samples that do and do not belong to the indicated diet, 
respectively.  For the control and OS-HA7 diets, all samples were spaced well away from the 0.5 
nominal threshold for class differentiation.  StA-HA7 had nearly all closed symbols positioned 
well above the 0.5 line, but one sample appeared slightly above the nominal threshold.  HA7 had 
three of its samples positioned above the 0.5 line, but one sample appeared below the threshold 
line.  Nevertheless, it is readily classified as HA7 because its class-fit values for all of the other 
diets were even lower.    
 PLS-DA fingerprint analysis for the cecal contents was also carried out for the antibiotic 
subgroup treatments.  The cecal contents PLS-DA antibiotic analysis had no training-set 
misclassifications.  In Fig. 6, only two verification-set samples were misclassified.  Thus, the 
PLS-DA statistical classification separated the cecal contents antibiotic and saline treatments 
well.   
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Fig. 5  PLS-DA analysis of cecal-content 
verification-set samples for diet treatments, 
including AOM- and antibiotic-treated samples.  
The solid markers represent the samples that 
belong to the tested class and should ideally 
have a class fit value of 1.0.  The open markers 
correspond to samples which do not belong to 
the tested class and ideally have a class fit of 0    
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Fig. 6  PLS-DA analysis of cecal and distal 
colon content verification-set samples for 
antibiotic treatment, including diets and AOM-
treated samples.  The solid markers represent the 
samples that belong to the tested class and 
should ideally have a class fit value of 1.0.  The 
open markers correspond to samples that do not 
belong to the tested class and ideally have a 
class fit of 0 
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Classifying the cecal-content samples 
by AOM subgroup treatment was much less 
successful (data not shown).  PLS-DA was able 
to produce a model for AOM treatment 
classification that properly predicted all of the 
training-set samples, but its analysis yielded 13 
misclassifications among the 20 verification-set 
samples.  Clearly, at the time the animals were 
sacrificed and the samples taken, 8 weeks after 
the last AOM injection, the AOM treatment 
had too little effect on the cecal contents to be 
observed via mass spectrometry.   
 
Statistical analysis of distal colon contents 
 
 Classification analysis was also 
performed for the spectra of the distal colon 
contents RS groups.  PLS-DA was performed 
with a 54-sample training set and 18-member 
verification set.  The verification set contained 
six, three, three, and six samples from the 
control, HA7, OS-HA7, and StA-HA7 diets, 
respectively.  The PLS-DA diet group analysis 
of the distal colon contents misclassified only 
one verification-set sample.  Figure 7 shows 
the PLS-DA verification-set analysis of the 
distal colon contents.  The distal-colon-
contents categorization for the diet samples 
was not as clean as it was for the cecal contents.  The HA7, OS-HA7, and StA-HA7 diets have 
all of their markers in the correct region above or below the 0.5 class-fit threshold, but many 
markers occur very close to the threshold. The control diet classification clearly shows all of the 
errant samples.  In the control diet classification, one control sample fell below the 0.5 class-fit 
threshold, but it still correctly classified due to its class-fit value being closest to one for the 
control group.  The other errant sample in the control-diet classification is the open, inverted 
triangle (StA-HA7 sample) at a control-diet class-fit value of 0.76.  This same sample 
corresponds to the highest filled triangle in the StA-HA7 classification (class-fit value 1.45).  
Because the class-fit value for the sample in the control diet class is closer to one, the sample 
was misclassified as belonging to the control diet.    
PLS-DA analysis of the distal-colon-contents training set for antibiotic treatment had no 
misclassified samples.  The PLS-DA verification set in Fig. 6 contained four misclassified 
samples.  The PLS-DA classification was able only to modestly separate distal colon antibiotic 
and saline subgroup treatments.   It has been observed that antibiotics have a profound effect on 
the microbial gut community and metabolic processes in mice [42].  A cultured gut microbial 
community can return to pre-antibiotic treatment levels approximately 3 weeks after treatment 
[53, 54].  A metabolic study also determined that urinary and fecal metabolites of mice return to 
near control conditions 3 weeks after antibiotic treatment [55].  However, a comprehensive 
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Fig. 7  PLS-DA analysis of distal colon-content 
verification-set samples for diet treatments, 
including AOM- and antibiotic-treated samples.  
The solid markers represent the samples that 
belong to the tested class and should ideally 
have a class fit value of 1.0.  The open markers 
correspond to samples that do not belong to the 
tested class and ideally have a class fit of 0 
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pyrosequencing study of the gut microbiome found that antibiotic recovery did not return to the 
initial conditions, even after 6 weeks [56].   
Our findings are consistent with long-term antibiotic perturbations to the gut microbiome. 
Eight weeks after the antibiotic treatment, the cecal contents antibiotic treatment was still well 
separated from the saline treatment, and distal colon antibiotic treatment was modestly different 
from the saline treatment (Fig. 6).    
The distal colon PLS-DA modeling of the training set for AOM treatment had no 
misclassifications.  The verification set for the PLS-DA analysis had four misclassifications (data 
not shown).  AOM is a carcinogen and promotes the growth of preneoplastic lesions in the colon.  
Previous work had suggested that a RS diet decreased the levels of preneoplastic lesions in rats 
given AOM [47] but preneoplastic lesions in the animals used for this study were not appreciably 
different among the four diet treatments (unpublished data).  As described above, the cecum 
metabolite profile was not greatly affected by the AOM treatment.  The PLS-DA distal colon 
analysis does appear to show that AOM may have had a minor effect on the metabolite profile in 
the distal colon.  This could be attributed to the possibility that lesions would appear in the colon, 
rather than the cecum.  These lesions thus would most likely not have a large effect upstream on 
the cecal metabolites. 
 
Biomarkers from resistant starch diets 
 
 An effort was made to locate a small group of distinctive metabolites from the cecal and 
distal colon contents diet treatments as indicators or biomarkers for the diets.  The statistical 
analysis of the cecal and distal colon contents yielded a vector regression plot for each diet (data 
not shown).  The regression vectors indicated how strongly each m/z peak contributed to the 
PLS-DA classification of the parent diet in relation to the three diets by assigning each m/z peak 
a relative intensity.  Mass spectral peaks that contributed a substantial weight to the variation and 
classification of the diets gave a strong, positive vector intensity for that diet.  The absolute 
normalized intensity of a m/z peak within a specific diet in relation to the other diets did not 
necessarily predict a large vector regression coefficient.  In many cases, m/z peaks had analogous 
intensities among multiple groups, but was considered a biomarker for only a single group.  That 
biomarker had a high regression coefficient because the m/z peak was a key component in 
classifying that diet group from the others.    
For both cecal and distal colon contents analysis, the five or six metabolites with the 
strongest positive regression-vector values were examined as potential biomarkers.  The accurate 
m/z values of these potential biomarkers were compared against the KEGG database using 
MassTRIX [50].  The accurate mass of the biomarkers matched within an accuracy of ±0.005 
Da.   
The potential biomarkers from each RS diet for cecal and distal colon contents are shown 
in Table 2.  The biomarkers comprise a variety of compound classes ranging from amino acids 
and glucose to various steroids.  Amino acids appear often among many of the diet categories; 
proline, leucine, isoleucine, valine, methionine, and phenylalanine are all present.  In many 
cases, the amino acid biomarkers that are prevalent in the cecal contents are not prevalent enough 
to be chosen as biomarkers for the distal colon contents.  The control diet was the only diet to 
retain an amino acid biomarker, proline, between cecal and distal colon contents.  By contrast, 
the control diet has leucine or isoleucine only in the cecum, while methionine appears only in the 
distal colon contents list.  It is not apparent why the RS diets would have such variations in the 
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prevalence of amino acid biomarkers, but the large differences between the cecum and the distal 
colon could be due to host absorption or differences in the bacterial community induced by the 
different diets.  Table 2 also shows that many biomarkers are conserved in both the cecal and 
distal colon contents. Biomarkers with the m/z of 116.071, 148.134, 251.128, 321.240, 336.228, 
357.239, and 595.352 were observed in the cecal and distal contents in their respective diet 
groups.  The similarity in the biomarkers between the cecal and distal colon contents correspond 
well with Fig. 4.  The Fig. 4 control and StA-HA7 diets contained many of the same cecal and 
distal-colon contents m/z peaks.  Thus, many of the most prominent biomarkers could transit the 
large intestine.   
 
 
Conclusions 
 
 Metabolite extracts of rat cecal and distal colon contents from the starch diets could be 
accurately fingerprinted using PLS-DA.  The PLS-DA verification-set plots showed that the diet 
groups for the cecal and distal colon contents could be distinguished from each other.  Utilizing 
PLS-DA, the antibiotic subgroup treatments were divided well for the cecal contents and 
modestly separated for the distal colon contents.  Thus, the digestive system of the rats had most 
likely regained normal function following antibiotic treatment, but had different microbial 
communities.  The AOM- and saline-treated rats partially separated based on the distal colon 
contents, but failed to separate for the cecal contents.  The AOM treatment may not have had an 
effect on the cecum due to AOM targeting the colon or the time frame of AOM-induced 
carcinogenesis may not have been reached.   
Future proposed work will involve studying changes in metabolites over time within the 
period immediately following administration of the diet.  Compounds that appear to change over 
time will be compared to biomarkers in this study in an attempt to improve understanding of RS 
digestion.  In addition due to the variety of biomarker compounds, parallel companion studies 
will be run to observe polar or nonpolar metabolites and to definitely identify observed 
compounds using MS/MS or GC/MS.     
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Table 1 
Metabolite peaks found in (C) cecal and (D) distal colon samples as shown in Figs. 1, 2, and 3 
 
Peak  m/z Control  HA7 OS-HA7 StA-HA7 
a 116.071 D D 
b 118.087 D C D C D C D 
c 121.065 C 
d 132.102 C D C D C D C D 
e 141.066 C C 
f 141.112 C C 
g 148.134 C D C C D 
h 166.087 C D C D C D 
i 173.129 C C 
j 195.113 C D C D 
k 212.14 C C C D 
l 217.104 D 
m 229.151 D 
n 230.187 C D C D 
o 242.187 D 
p 251.128 C D 
q 273.108 D 
r 276.134 C D C D 
s 277.129 C D C C D 
t 321.240 C D 
u 335.219 C 
v 336.228 D D 
w 357.239 C D 
x 373.274 D D 
y 377.265 C 
z 378.269 C 
aa 379.280 C 
ab 393.242 C C 
ac 409.164 D 
ad 479.263 C D 
ae 501.246 D 
af 563.268 D 
ag 591.322 C 
ah 595.352 D C D 
ai 733.559 C 
aj 737.286 C D 
ak 839.565       C D 
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Table 2 
Biomarkers with substantial contribution to class differentiation matched to KEGG Database 
  
Cecal contents m/z Compounda 
Molecular 
Formula 
Control 116.071 Proline [M+H]+ C5H9NO2 
132.102 Leucine [M+H]+ C6H13NO2 
132.102 Isoleucine [M+H]+ C6H13NO2 
148.134 No database match Unknown 
377.265 3-acetyl-5alpha-androstane-3beta,17beta-diol C23H36O4 
3-acetate [M+H]+ 
595.350 L-Stercobilin [M+H]+ C33H46N4O6 
HA7 diet 118.087 Valine [M+H]+ C5H11NO2 
141.113 2-Methylcholine [M+Na]+ C6H16NO 
161.093 Alanyl-alanine [M+H]+ C6H12N2O3 
161.093 Nonadienal [M+Na]+ C9H14O 
203.053 Glucose [M+Na]+ C6H12O6 
336.228 12-hydroxyicosa-trienoic acid [M+H]+ C20H31O4 
OS-HA7 251.129 Methylripariochromene A [M+H]+ C14H18O4 
294.157 No database match Unknown 
357.238 Allotetrahydrodeoxycorticosterone [M+Na]+ C21H34O3 
479.263 No database match Unknown 
591.322 Urobilin [M+H]+ C33H42N4O6 
591.322 Deoxycholic acid 3-glucuronide [M+Na]+ C30H48O10 
StA-HA7 242.187 No database match C17H23N 
276.134 Alanyltryptophan [M+H]+ C14H17N3O3 
277.129 Homoanserine [M+Na]+ C11H18N4O3 
321.240 Oxooctadecanoic acid [M+Na]+ C18H34O3 
321.240 Hydroxy-eicosatetraenoic acid [M+H]+ C20H32O3 
335.219 Hydroperoxy, octadecadienoic acid [M+Na]+ C18H32O4 
    
Distal contents m/z Compounda 
Molecular 
Formula 
Control 116.071 Proline [M+H]+ C5H9NO2 
141.111 2-Methylcholine [M+Na]+ C6H16NO 
148.134 No database match Unknown 
150.059 Methionine [M+H]+ C5H11NO2S 
595.353 L-Stercobilin [M+H]+ C33H46N4O6 
HA7 diet 230.187 No database match Unknown 
254.155 Gamma-aminobutyryl-lysine [M+Na]+ C10H21N3O3 
255.147 Homoanserine [M+H]+ C11H18N4O3 
336.228 12-Hydroxyicosa-trienoic acid [M+H]+ C20H31O4 
563.268 Protoporphyrin [M+Na]+ C34H34N4O4 
16 
 
OS-HA7 118.087 Valine [M+H]+ C5H11NO2 
212.140 No database match Unknown 
251.127 Methylripariochromene A [M+H]+ C14H18O4 
294.162 No database match Unknown 
357.240 Allotetrahydrodeoxycorticosterone [M+Na]+ C21H34O3 
737.286 No database match Unknown 
StA-HA7 116.071 Proline [M+H]+ C5H9NO2 
124.039 Picolinic acid [M+H]+ C6H5NO2 
166.087 Phenylalanine [M+H]+ C9H11NO2 
166.087 Stachydrine [M+Na]+ C7H13NO2 
212.140 No database match Unknown 
321.240 Oxooctadecanoic acid [M+Na]+ C18H34O3 
321.240 Hydroxy-eicosatetraenoic acid [M+H]+ C20H32O3 
409.164 Burseran [M+Na]+ C22H26O6 
409.164 1,2-Dihydro-5-hydroxy-2-(1-hydroxy-1- C24H24O6 
methylethyl)-4-(isobutyryl)-6-phenylfurano 
[2,3-h][1]benzopyran-8-one [M+H]+ 
aNotation refers to the stated molecule (M) and the observed adduct bracketed with the positive charge 
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